Interventional Management of Stroke III - IMS III


Intravenous (IV) tissue plasminogen activator (t-PA) is recommended within 4.5 hours of onset of symptoms for patients with acute ischemic stroke. However, t-PA is less efficacious in the setting of large thrombus burdens, especially in large vessels. The current trial sought to study the safety and efficacy of routine endovascular intervention in patients presenting within 3 hours of stroke onset.